Figure 8From: Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR ratsImpact of timed daily bromocriptine or vehicle administration on fatty acid oxidation activators – PGC1α (Panel A), PPARα (Panel B), and PPARγ (Panel C). Proteins we quantified by Western blotting. Values are means ± SEM of 8 animals in each group. *Difference is statistically significant; P values are noted under each panel.Back to article page